Comparison of Intraperitoneal Bupivacaine Alone or With Dexmedetomidine

NACompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

June 30, 2024

Study Completion Date

June 30, 2024

Conditions
LAPAROSCOPIC CHOLECYSTECTOMY
Interventions
DRUG

Bupivacaine injection

patients received intraperitoneal bupivacaine 50 ml 0.25% + 5 ml normal saline.

DRUG

Dexmedetomidine injection

Patients were given intraperitoneal bupivacaine 50 ml 0.25% + dexmedetomidine 1 μg/kg with normal saline 5 ml.

Trial Locations (1)

06318

Quaid-e-Azam Medical College, Bahawalpur

All Listed Sponsors
collaborator

Bahawal Victoria Hospital

UNKNOWN

lead

RESnTEC, Institute of Research

OTHER

NCT06560892 - Comparison of Intraperitoneal Bupivacaine Alone or With Dexmedetomidine | Biotech Hunter | Biotech Hunter